Lupin launches generic joint pain drug in US market

Lupin launches generic joint pain drug in US market

The company's product- Diclofenac Sodium Topical Solution 2 per cent- is the generic version of Horizon Pharma Therapeutics Pennsaid

PTIUpdated: Friday, December 09, 2022, 03:17 PM IST
article-image
Image credit: Wikipedia (Representative)

Lupin announced on Friday that it has launched a generic version of Pennsaid, which is used to treat knee pain caused by osteoarthritis, in the American market.

The company's product- Diclofenac Sodium Topical Solution 2 per cent- is the generic version of Horizon Pharma Therapeutics Pennsaid, Lupin said in a statement.

As per IQVIA MAT October 2022 data, Lupin said diclofenac sodium topical solution, 2 per cent, had estimated annual sales of USD 509 million in the US.

RECENT STORIES

India’s $30 Billion FII Test And 60% Debt-To-GDP Discipline, Why AI, Capital Reforms & The 4Ps...
India’s $30 Billion FII Test And 60% Debt-To-GDP Discipline, Why AI, Capital Reforms & The 4Ps...
RBI Tightens Broker Funding Norms, 100% Collateral Mandatory From April 2026; No Bank Support For...
RBI Tightens Broker Funding Norms, 100% Collateral Mandatory From April 2026; No Bank Support For...
Mumbai Real Estate News: Reliance Industries Buys 3 Luxury Homes At One Altamount Road For ₹85...
Mumbai Real Estate News: Reliance Industries Buys 3 Luxury Homes At One Altamount Road For ₹85...
Government Approves Startup India 2.0 With ₹10,000 Crore Corpus To Boost Deep Tech & Regional...
Government Approves Startup India 2.0 With ₹10,000 Crore Corpus To Boost Deep Tech & Regional...
Signature Global Forms 50:50 JV With RMZ Group For ₹1,283 Crore Gurugram Mixed-Use Project
Signature Global Forms 50:50 JV With RMZ Group For ₹1,283 Crore Gurugram Mixed-Use Project